Ardent Health Reports Second Quarter 2024 Results

Go back to Ardent Health Reports Second Quarter 2024 Results

Ardent Health Partners Inc (ARDT) PT Raised to $22 at Truist Securities

August 16, 2024 6:02 AM EDT

Truist Securities analyst David MacDonald raised the price target on Ardent Health Partners Inc (NYSE: ARDT) to $22.00 (from $21.00) while maintaining a Buy rating.

The analyst comments "We remain bullish on Ardent Health following 2Q results featuring top-line/volume strength and solid cost... More